We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$12B
AUM Growth
-$353M
Cap. Flow
-$617M
Cap. Flow %
-5.16%
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191

Top Buys

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$140M
2
ABBV icon
AbbVie
ABBV
+$119M
3
KEY icon
KeyCorp
KEY
+$115M
4
FFIV icon
F5
FFIV
+$111M
5
WMT icon
Walmart Inc
WMT
+$110M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$146M
2
SPGI icon
S&P Global
SPGI
+$142M
3
LLY icon
Eli Lilly
LLY
+$133M
4
LH icon
Labcorp
LH
+$131M
5
RHT
Red Hat Inc
RHT
+$121M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Healthcare 13.19%
3 Industrials 12.91%
4 Consumer Discretionary 10.27%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
101
Medtronic
MDT
$111B
$42.8M 0.36%
+482,264
New +$40.7M
WFM
102
DELISTED
Whole Foods Market Inc
WFM
$42.1M 0.35%
1,000,000
-932,902
-48% -$34M
DVA icon
103
DaVita
DVA
$15B
$41.8M 0.35%
+644,736
New +$42.7M
FLIR
104
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$41.6M 0.35%
1,200,383
+314,254
+35% +$11.5M
TSRO
105
DELISTED
TESARO, Inc.
TSRO
$41.5M 0.35%
296,685
-151,688
-34% -$22M
BIIB icon
106
Biogen
BIIB
$29.8B
$40.6M 0.34%
+149,507
New +$39.5M
SITC icon
107
SITE Centers
SITC
$174M
$40.3M 0.34%
3,445,733
+3,238,819
+1,565% +$42.3M
TTWO icon
108
Take-Two Interactive
TTWO
$45.8B
$39.7M 0.33%
541,147
-43,255
-7% -$2.96M
PII icon
109
Polaris
PII
$4.02B
$39.6M 0.33%
+428,954
New +$36.8M
PF
110
DELISTED
Pinnacle Foods, Inc.
PF
$39.5M 0.33%
665,089
-30,280
-4% -$1.81M
VEAC
111
DELISTED
Vantage Energy Acquisition Corp. Class A
VEAC
$39M 0.33%
+3,999,999
New +$39.1M
BHC icon
112
Bausch Health
BHC
$2.62B
$38.8M 0.32%
2,241,254
-685,687
-23% -$8.22M
YELP icon
113
Yelp
YELP
$1.47B
$38.3M 0.32%
1,277,306
+781,789
+158% +$24.4M
CUDA
114
DELISTED
Barracuda Networks, Inc.
CUDA
$38M 0.32%
1,647,584
+544,761
+49% +$12M
P
115
DELISTED
Pandora Media Inc
P
$38M 0.32%
4,259,120
+2,724,136
+177% +$26.2M
ZBH icon
116
Zimmer Biomet
ZBH
$18.8B
$37.5M 0.31%
+300,705
New +$35.7M
A icon
117
Agilent Technologies
A
$39.5B
$36.8M 0.31%
621,075
-1,757,255
-74% -$100M
USFD icon
118
US Foods
USFD
$21.9B
$35.6M 0.3%
1,307,615
+557,615
+74% +$15.9M
DLTR icon
119
Dollar Tree
DLTR
$24.9B
$35.5M 0.3%
+507,555
New +$39.2M
DELL icon
120
Dell
DELL
$277B
$35.4M 0.3%
2,065,406
-961,547
-32% -$17.6M
GIMO
121
DELISTED
Gigamon Inc.
GIMO
$34.8M 0.29%
+883,389
New +$33.3M
GTYH
122
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$34.3M 0.29%
+3,400,099
New +$33.9M
ULTA icon
123
Ulta Beauty
ULTA
$23B
$33.5M 0.28%
116,690
-8,043
-6% -$2.35M
ARRS
124
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$33.5M 0.28%
1,194,713
-1,340,526
-53% -$36.8M
AGO icon
125
Assured Guaranty
AGO
$3.72B
$32.6M 0.27%
780,748
-105,717
-12% -$4.17M
3 4
5
6 7

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q2 2017 Portfolio in Review

As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.

  • Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
  • Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
  • Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
  • Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
  • Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
  • Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.

Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.